BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26258887)

  • 1. PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.
    Iansante V; Choy PM; Fung SW; Liu Y; Chai JG; Dyson J; Del Rio A; D'Santos C; Williams R; Chokshi S; Anders RA; Bubici C; Papa S
    Nat Commun; 2015 Aug; 6():7882. PubMed ID: 26258887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation.
    Gao F; Zhang X; Wang S; Zheng L; Sun Y; Wang G; Song Z; Bao Y
    Cell Death Dis; 2021 May; 12(6):517. PubMed ID: 34016961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
    Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
    PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation.
    Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G
    Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
    Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
    Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.
    Barbarulo A; Iansante V; Chaidos A; Naresh K; Rahemtulla A; Franzoso G; Karadimitris A; Haskard DO; Papa S; Bubici C
    Oncogene; 2013 Sep; 32(36):4231-42. PubMed ID: 23045269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
    Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
    J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
    J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.
    Tai WT; Hung MH; Chu PY; Chen YL; Chen LJ; Tsai MH; Chen MH; Shiau CW; Boo YP; Chen KF
    Oncotarget; 2016 Apr; 7(16):22193-205. PubMed ID: 26959741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway.
    Ye G; Qin Y; Wang S; Pan D; Xu S; Wu C; Wang X; Wang J; Ye H; Shen H
    Cancer Biol Ther; 2019; 20(5):711-719. PubMed ID: 30755064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z; Wang Z; Guo W; Zhang Z; Zhao F; Zhao Y; Jia D; Ding J; Wang H; Yao M; He X
    Oncogene; 2015 Jul; 34(30):3946-56. PubMed ID: 25263439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
    Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
    Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
    Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.
    Zhang LF; Lou JT; Lu MH; Gao C; Zhao S; Li B; Liang S; Li Y; Li D; Liu MF
    EMBO J; 2015 Nov; 34(21):2671-85. PubMed ID: 26346275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.